CXXIF (C21 Investments) Days Inventory: 95.93 (As of Mar. 2026) — Near Median


CXXIF C21 Investments Inc CXXIF
37 GF Score
Price $0.24
GF Value $0.28
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is C21 Investments Days Inventory?

C21 Investments CXXIF +6.73% 37 Days Inventory is 95.93 as of Mar. 2026, which is 6% above its 10-year median of 90.64. GuruFocus rates CXXIF with a GF Score™ of 37/100 and a GF Value™ of $0.28 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 923 Drug Manufacturers companies, C21 Investments ranks better than 84.83% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). C21 Investments's Average Total Inventories for the three months ended in Mar. 2026 was $4.42 Mil. C21 Investments's Cost of Goods Sold for the three months ended in Mar. 2026 was $4.21 Mil. Hence, C21 Investments's Days Inventory for the three months ended in Mar. 2026 was 95.93.

The historical rank and industry rank for C21 Investments's Days Inventory or its related term are showing as below:

CXXIF' s Days Inventory Range Over the Past 10 Years
Min: 68.43   Med: 90.64   Max: 1326.04
Current: 84.55

During the past 13 years, C21 Investments's highest Days Inventory was 1326.04. The lowest was 68.43. And the median was 90.64.

CXXIF's Days Inventory is ranked better than
84.83% of 923 companies
in the Drug Manufacturers industry
Industry Median: 164.48 vs CXXIF: 84.55

C21 Investments's Days Inventory increased from Mar. 2025 (80.86) to Mar. 2026 (95.93). It might indicate that C21 Investments's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. C21 Investments's Inventory Turnover for the three months ended in Mar. 2026 was 0.95.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. C21 Investments's Inventory-to-Revenue for the three months ended in Mar. 2026 was 0.59.


C21 Investments  (OTCPK:CXXIF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

C21 Investments's Inventory Turnover for the three months ended in Mar. 2026 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

C21 Investments's Inventory to Revenue for the three months ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


C21 Investments Days Inventory Related Terms


C21 Investments Days Inventory Historical Data

* Premium members only.

The historical data trend for C21 Investments's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

C21 Investments Days Inventory Chart

C21 Investments Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Mar25 Mar26
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 86.88 96.96 73.31 70.26 82.97

C21 Investments Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.86 67.29 96.96 81.85 95.93

CXXIF vs ZTS, UTHR: Days Inventory Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments Days Inventory vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's Days Inventory distribution charts can be found below:

* The bar in red indicates where C21 Investments's Days Inventory falls into.


CXXIF
37GF Score
C21 Investments Inc CXXIF
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

C21 Investments Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

C21 Investments's Days Inventory for the fiscal year that ended in Mar. 2026 is calculated as

Days Inventory (A: Mar. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Mar. 2025 ) + Total Inventories (A: Mar. 2026 )) / count ) / Cost of Goods Sold (A: Mar. 2026 )*Days in Period
=( (4.051 + 4.591) / 2 ) / 19.01*365
=4.321 / 19.01*365
=82.97

C21 Investments's Days Inventory for the quarter that ended in Mar. 2026 is calculated as:

Days Inventory (Q: Mar. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (4.257 + 4.591) / 2 ) / 4.208*365 / 4
=4.424 / 4.208*365 / 4
=95.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 95.93 mean?
C21 Investments (CXXIF) has a Days Inventory of 95.93 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on C21 Investments and its competitors. This is near median its historical median of 90.64. Over the past decade, C21 Investments' Days Inventory has ranged from 68.43 to 1,326.04. According to the industry distribution chart, C21 Investments ranks #140 out of 923 companies in the Drug Manufacturers industry, placing it in the top 15.2%.
Is C21 Investments' Days Inventory too high?
C21 Investments' current Days Inventory of 95.93 is near median its 10-year median of 90.64. Over the past 10 years, this metric has ranged from a low of 68.43 to a high of 1,326.04. The Drug Manufacturers industry median Days Inventory is 164.48. C21 Investments' value of 95.93 is 41.7% below this industry median. Based on the distribution chart, C21 Investments ranks #140 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, C21 Investments has a GF Score™ of 37/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does C21 Investments' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, C21 Investments ranks #140 out of 923 companies for Days Inventory. This places C21 Investments in the top 15% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. C21 Investments' value of 95.93 is 41.7% below this benchmark. Historically, C21 Investments' own Days Inventory has ranged from 68.43 to 1,326.04 over the past decade. While the company's 10-year median is 90.64 vs. the industry median of 164.48, C21 Investments has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. C21 Investments's current Days Inventory of 95.93 is 41.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on C21 Investments and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. C21 Investments's current Days Inventory is 95.93, which is near median its own 10-year median of 90.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is C21 Investments stock overvalued right now?
Based on GuruFocus' analysis, C21 Investments (CXXIF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.28, compared to a current price of $0.24 — trading 12.8% below its estimated fair value. The current Days Inventory is 95.93, which is near median its 10-year median of 90.64 and 41.7% below the Drug Manufacturers industry median of 164.48. C21 Investments' overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For C21 Investments (CXXIF), the current Days Inventory is 95.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is C21 Investments (CXXIF) Overvalued in 2026?

Based on GuruFocus' analysis, C21 Investments stock appears to be undervalued. The current stock price of $0.24 is trading 12.8% below its estimated GF Value™ of $0.28. GuruFocus considers C21 Investments to be Modestly Undervalued.

Key valuation signals for CXXIF:

  • Days Inventory: 95.93 (near median its 10-year median of 90.64)
  • GF Value™: $0.28 vs. price of $0.24 (12.8% below fair value)
  • GF Score™: 37/100 with 4 warning signs
  • Industry Position: 41.7% below the Drug Manufacturers median (#140 of 923)

No single metric tells the full story. See the CXXIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


C21 Investments Business Description

Other Exchanges CXXI:Canada
Address 885 West Georgia Street, Floor 19, Vancouver, BC, CAN, V6C 3H4
C21 Investments Inc is a vertically integrated cannabis company that cultivates, processes, distributes, and sells quality cannabis and hemp-derived consumer products in Nevada, U.S.A., and the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets, leveraging industry retail revenues with high-growth potential and multi-market branded consumer packaged goods (CPG). The Company focuses on scalable opportunities in key markets through retail operational excellence, expanding its retail footprint through value-add acquisitions in existing markets, and branded CPG expansion through captive retail and wholesale channels.
37GF Score

Get the complete analysis for CXXIF

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.24
Price
$0.28
GF Value